Triana Biomedicines

Triana Biomedicines

Edit info

  • Founded: 2020
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: Undisclosed
  • Funding: $110M A Mar 2022


trianabio.com

linkedin.com

job board


Business:

Platform to discover and develop molecular glues - E3 ubiquitin ligases

About:

Triana Biomedicines is using technology to identify “molecular glues” which are small molecules that interact with a disease target protein to change its function. This approach allows for the development of precision medicine that can transform patient lives. Estimates suggest that roughly 85% of disease targets are undruggable. Triana Biomedicines is addressing this with their innovative “molecular glues” which allow them to pursue relevant disease targets that have been deemed undruggable. Specifically, these molecules induce the disease target protein to be “glued” to the components of the cell’s ubiquitin-proteasome system and degraded. Triana Biomedicines is using this targeted protein degradation approach to discover and develop new small molecules with immense therapeutic benefit.

Post a job


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com